Analysis of the European HIV Drugs Market

Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

Regular Price: USD 4,950

Special Price USD 4,208

15% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,208

PAY BY INVOICE

Be the first to review this product

This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary—Market Engineering MeasurementsExecutive Summary—Market Engineering Measurements (continued)Executive Summary—CEO’s PerspectiveMarket OverviewMarket Overview—Scope of the StudyMarket Overview—DefinitionsMarket Overview—Definitions (continued)Market Overview—Key Questions This Study Will AnswerMarket Overview—Segmentation based on Types of ARV Therapy Market Overview—Segmentation based on Types of ARV Therapy (continued) Market Overview—Segmentation based on GeographyMarket Overview—Segmentation based on Geography (continued)External Challenges: Drivers and Restraints—Total HIV Drugs MarketDrivers and RestraintsDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Impact Mapping of Drivers and RestraintsForecast and Trends—Total HIV Drugs MarketMarket Engineering MeasurementsMarket Engineering Measurements (continued)Forecast AssumptionsTotal HIV Drugs Market—Revenue ForecastTotal HIV Drugs Market—Revenue Forecast by SegmentRevenue Forecast DiscussionTotal HIV Drugs Market—Growth Analysis by SegmentTotal HIV Drugs Market—Per cent Revenue Forecast by RegionTotal HIV Drugs Market—Revenue Forecast by RegionRegional Revenue Forecast DiscussionHIV Drugs Market—Metrics AnalysisPEST AnalysisMarket Share and Competitive Analysis— Total HIV Drugs MarketCompetitive Analysis—Market ShareMarket Share AnalysisMarket Share Analysis (continued)Competitive EnvironmentHIV Drugs Market—Competitive LandscapeMarketed Product Analysis Marketed Product Analysis (continued)Marketed Product Analysis (continued)Key Pipeline Products by Segment Key Pipeline Products by Segment (continued)Key Pipeline Products by Segment (continued)Key Pipeline Products by Segment (continued)Key Pipeline Products—AnalysisNRTI Segment BreakdownNRTI Segment OverviewNRTI Segment—Market Engineering MeasurementsNRTI Segment—Revenue ForecastNRTI Segment—Revenue Forecast DiscussionNRTI Segment—Metrics AnalysisNRTI Segment—Impact of Key Market TrendsPI Segment BreakdownPI Segment OverviewPI Segment—Market Engineering MeasurementsPI Segment—Revenue ForecastPI Segment—Revenue Forecast DiscussionPI Segment—Metrics AnalysisPI Segment—Impact of Key Market TrendsNNRTI Segment BreakdownNNRTI Segment OverviewNNRTI Segment—Market Engineering MeasurementsNNRTI Segment—Revenue ForecastNNRTI Segment—Revenue Forecast DiscussionNNRTI Segment—Metrics AnalysisNNRTI Segment—Impact of Key Market TrendsIntegrase Inhibitor Segment BreakdownIntegrase Inhibitor Segment OverviewIntegrase Inhibitor Segment—Market Engineering MeasurementsIntegrase Inhibitor Segment—Revenue ForecastIntegrase Inhibitor Segment—Revenue Forecast DiscussionIntegrase Inhibitor Segment—Metrics AnalysisIntegrase Inhibitor Segment—Impact of Key Market TrendsOther Therapeutics Segment BreakdownOther Therapeutics Segment OverviewOther Therapeutics Segment—Market Engineering MeasurementsOther Therapeutics Segment—Revenue ForecastOther Therapeutics Segment—Revenue Forecast DiscussionThe United Kingdom BreakdownThe United Kingdom Market—IntroductionThe United Kingdom Market—Market Engineering MeasurementsThe United Kingdom Market—Revenue ForecastThe United Kingdom Market—Revenue Forecast DiscussionThe United Kingdom Market—Key Trends and ImplicationsGermany BreakdownGermany Market—IntroductionGermany Market—Market Engineering MeasurementsGermany Market—Revenue ForecastGermany Market—Revenue Forecast DiscussionGermany Market—Key Trends and ImplicationsFrance BreakdownFrance Market—IntroductionFrance Market—Market Engineering MeasurementsFrance Market—Revenue ForecastFrance Market—Revenue Forecast DiscussionFrance Market—Key Trends and ImplicationsSpain BreakdownSpain Market—IntroductionSpain Market—Market Engineering MeasurementsSpain Market—Revenue ForecastSpain Market—Revenue Forecast DiscussionSpain Market—Key Trends and ImplicationsItaly BreakdownItaly Market—IntroductionItaly Market—Market Engineering MeasurementsItaly Market—Revenue ForecastItaly Market—Revenue Forecast DiscussionItaly Market—Key Trends and ImplicationsBenelux BreakdownBelgium Market—IntroductionThe Netherlands Market—IntroductionLuxembourg Market—IntroductionBenelux Market—Market Engineering MeasurementsBenelux Market—Revenue ForecastBenelux Market—Revenue Forecast DiscussionBenelux Market—Key Trends and ImplicationsScandinavia BreakdownDenmark Market—IntroductionNorway Market—IntroductionSweden Market—IntroductionFinland Market—IntroductionScandinavia Market—Market Engineering MeasurementsScandinavia Market—Revenue ForecastScandinavia Market—Revenue Forecast DiscussionScandinavia Market—Key Trends and ImplicationsThe Last WordConclusions—European HIV Drugs MarketThe Last Word—Three Big PredictionsLegal DisclaimerAppendixMarket Engineering MethodologyDatabase of Key Industry ParticipantsAdditional Sources of InformationPrevalence of HIVIncidence of AIDSMortality Due to AIDS




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : North America

Release Date : 17-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.